Plasma Metabolomic Profiling in Patients with Rheumatoid Arthritis Identifies Biochemical Features Predictive of Quantitative Disease Activity
Arthritis Research & Therapy (2021): https://arthritis-research.biomedcentral.com/articles/10.1186/s13075-021-02537-4
Authors: Benjamin Hur, Vinod K. Gupta, Harvey Huang, Kerry A. Wright, Kenneth J. Warrington, Veena Taneja, John M. Davis III, and Jaeyun Sung
Contact: hur.benjamin@mayo.edu Corresponding Author: sung.jaeyun@mayo.edu
src/linear_model_r1/MLR_R_categorical_diff_2class_v2.r
analysis/differential_abundance_public/2class/run.sh
src/machine_learning_public/All_IN_ONE_FeatureSelection_CV_LOO.py
analysis/selection_scheme_public/run.sh
Investigation of drugs (csDMARD, TNFi-bDMARD, non-TNFi-bDMARD, MTX, PRED) that affected the abundance of metabolites.
src/statistics/drug_effect_lmer_R.ipynb
Differentially abundant metabolites related test. Investigates whether confounding effects (drug, smoke, age, etc) differs between higher and lower disease activity.
src/statistics/ftest_comfounds.ipynb
Investigation of prescription (csDMARD, TNFi-bDMARD, non-TNFi-bDMARD, MTX, PRED) differences between visit 1 and visit 2.
code/statistics/mcnemar_test_R.ipynb
preprocessed data: Training datset (n=128)
data/discovery_cohort
preprocessed data: Test dataset (n=12)
data/validation_cohort